Yomiuri: Kyoto Univ. Foundation, Itochu Develop Automated Production Kit for Patient-Derived iPS Cells

Dow Jones
09/08
 

By Yusuke Tomiyama

Yomiuri Shimbun Staff Writer

 

Kyoto University's CiRA Foundation and Itochu Corp. announced Friday that they have jointly developed a specialized kit to produce patient-derived iPS cells using fully automated culture devices.

The kit, which was developed through the foundation's My iPS Project, comprises multiple pouches (each approximately 1.5 to 2 liters) containing the necessary reagents, additives and other substances to produce the cells.

The development streamlines part of the production process and is expected to reduce costs.

According to Itochu, the pouches, which connect to the device, are highly sealed and facilitate automated cell culture without exposing the cells to the external environment. The foundation, which is led by Shinya Yamanaka, plans to begin supplying the kit to its collaborative research partners within the current fiscal year ending March 2026.

Producing iPS cells manually costs approximately 50 million yen per person. The foundation aims to reduce this to about 1 million yen per person by automating processes, including through the introduction of the kit.

----

This article is from The Yomiuri Shimbun. Neither Dow Jones Newswires, MarketWatch, Barron's nor The Wall Street Journal were involved in the creation of this content.

YDN-M0000141774-1

 

(END) Dow Jones Newswires

September 08, 2025 04:29 ET (08:29 GMT)

Copyright (c) 2025 The Yomiuri Shimbun

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10